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Abstract
Background: Enrichment of loci by DNA hybridization-capture, followed by high-throughput sequencing, is an
important tool in modern genetics. Currently, the most common targets for enrichment are the protein coding
exons represented by the consensus coding DNA sequence (CCDS). The CCDS, however, excludes many actual or
computationally predicted coding exons present in other databases, such as RefSeq and Vega, and non-coding
functional elements such as untranslated and regulatory regions. The number of variants per base pair (variant
density) and our ability to interrogate regions outside of the CCDS regions is consequently less well understood.
Results: We examine capture sequence data from outside of the CCDS regions and find that extremes of GC
content that are present in different subregions of the genome can reduce the local capture sequence coverage
to less than 50% relative to the CCDS. This effect is due to biases inherent in both the Illumina and SOLiD
sequencing platforms that are exacerbated by the capture process. Interestingly, for two subregion types,
microRNA and predicted exons, the capture process yields higher than expected coverage when compared to
whole genome sequencing. Lastly, we examine the variation present in non-CCDS regions and find that predicted
exons, as well as exonic regions specific to RefSeq and Vega, show much higher variant densities than the CCDS.
Conclusions: We show that regions outside of the CCDS perform less efficiently in capture sequence experiments.
Further, we show that the variant density in computationally predicted exons is more than 2.5-times higher than
that observed in the CCDS.
Background
Single nucleotide variants (SNVs) and short indels can
be discovered by hybridization-based targeted enrich-
ment, followed by high-throughput DNA sequencing.
This ‘capture sequencing’ can target the protein coding
regions of the genome, the ‘exome’, and provide a cost-
effective alternative to whole genome sequencing (WGS)
[1-6]. Capture sequencing has now been applied to the
identification of pathogenic variants in several disease
models [7-16] and in population studies comparing phe-
notypically normal individuals [17].
DNA may be enriched by a number of methods
[1,4,5,18]. Here, we perform liquid-phase hybridization
using biotinylated, DNA-oligonucleotide probes with a
typical length of 60 to 80 bp. The probes are incubated
with fragmented genomic DNA, after ligation with
sequencing-platform specific adapters. Subsequently, the
desired regions are recovered via streptavidin-coated
magnetic beads with affinity for the biotinylated oligo-
nucleotide probes. This approach has allowed interroga-
tion of a human exome, beginning with as little as 1 μg
of total DNA and with just 3 Gbp of total raw sequence
[6].
The consensus coding DNA sequence (CCDS) [19]
exons have been used most frequently to guide the
design of capture reagents because their gene models
are robust and encompass only approximately 30 Mbp.
The CCDS gene collection, however, is defined by con-
servative criteria and lacks many of the genes found in
other sets, such as RefSeq [20]. Even when two gene
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collections share the same core genes, the underlying
exon content of those genes may vary. Consequently,
the optimal design choice for targeting protein coding
regions is a matter of ongoing concern.
In addition, many regions related to gene function,
such as transcription factor binding sites, enhancer sites
and UTRs, exist outside of the coding exome. These ele-
ments may also contribute to disease pathogenicity and
are desirable components of target probe sets. Under-
standing the expected variant density of these regions
and our ability to sequence them are therefore impor-
tant considerations for designing future capture
experiments.
In order to expand the regions that can be effectively
targeted in capture sequence experiments, we designed
two new capture reagents, termed the VCR-set and
REC-set (Figure 1). The VCR-set targets the microRNA
(miRNA) [21], Vega [22], CCDS, and RefSeq gene
models, including predicted genes within RefSeq, with
a total target size of 42 Mbp. To evaluate its ability to
capture non-conserved UTRs, this design includes 8
Mbp of randomly selected UTR exons (see Materials
and methods). Our second capture design, the REC-set
(regulome, exons, conserved elements) aims to capture
a total genomic region of 52 Mbp. In addition to the
CCDS, RefSeq and Vega exons, the REC-set targets
conserved UTR elements [23,24], exons that have been
predicted computationally [25,26], as well as the
regulome, that is, regions believed to be involved in
transcription factor-mediated gene regulation [27-29].
These targeted regions represent a wide range of GC
contents (Figure 2).
The reagents developed here permitted us to deter-
mine the relative ‘capture ability’ of subregions of the
genome, compared to the CCDS. This measure can be
conflated by biases introduced through the sequencing
platform and alignment algorithms used. To assess the
specific effect of capture on enrichment, we compared
the levels of sequence coverage over specific genomic
loci to that of non-enriched, WGS at the same loci.
Results
In total, we aligned more than 54 Gbp of capture
sequence data derived from seven separate libraries and
five DNA samples to the human reference genome. The
data were generated using both VCR-set and REC-set
capture designs, and SOLiD (single-end) and Illumina
(paired-end) sequencing platforms.
For the REC-set design, two libraries were constructed
from DNA samples obtained from human blood, from
individuals of Hispanic ethnicity (L721, L722) for Illu-
mina sequencing. One SOLiD library was constructed
utilizing DNA from a HapMap cell-line (NA12812). The
VCR-set design was used to capture fragments of DNA
derived from two human blood samples from individuals
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Figure 1 Content and overlap of the VCR-set and REC-set designs. A hypothetical gene shows regions that would be targeted by the VCR-
set (orange), REC-set (green), both designs (orange/green) and CCDS (blue). TFBS, transcription factor binding site.
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sequencing, and two replicate libraries from the HapMap
cell line DNA (NA12812) followed by SOLiD sequencing.
We had previously reported that sequence data from
the Illumina platform routinely revealed a higher overall
sequence capture enrichment yield than that found
when using the SOLiD platform [6]. This was attributed
to the relative ease of generating ‘paired end’ reads on
the Illumina platform and the efficiency with which they
could subsequently be precisely mapped to the genome,
as well as differences in ligation strategies employed
during library construction (Supplementary Table 1 in
Additional file 1). Subsequent improvements in the
library construction protocols for SOLiD capture
sequencing have reduced the difference in the overall
sequence capture enrichment yields between platforms
(data not shown) [6]. To ensure meaningful comparison
of data generated on the different sequencing platforms,
we routinely ensured that the same number of targeted
bases were covered at ≥10× for each experiment.
Capture efficiency and coverage
Genomic subregions were defined as groups of genomic
segments with similar functional characteristics (UTRs,
predicted exons, and so on; Figure 1). The ‘capture-abil-
ity’ of each subregion was defined as the average
sequence coverage relative to the average coverage of
the CCDS subregion. As can be seen in Figure 3a, the
CCDS has approximately 10 to 15% higher average
coverage than the REC-set target regions as a whole.
Both the conserved UTR and regulome regions per-
formed substantially worse than the CCDS, whereas
predicted exons performed better than the CCDS.
Most of the subregions in the VCR-set design per-
formed within 10 to 20% of the CCDS (Figure 3b), the
only exception being the non-conserved UTR subre-
gion, which was substantially worse. Interestingly, the
miRNA subregion performed slightly better than the
CCDS when captured. For the majority of subregions,
Illumina and SOLiD sequencing performed identically,
with the exceptions of GC extremes (regulome, UTRs)
and regions that are consistently represented by ~100
bp in the genome (for example, miRNA). Results dif-
fered by less than 1% from sample to sample (data not
shown). Similar results were observed when consider-
ing the median level of coverage (Supplementary Fig-
ure 1 in Additional file 1), with the exception that the
coverage performance of the REC-set and VCR-set as a
whole was improved when compared to the CCDS.
This is due to some CCDS targets having extremely
high levels of coverage, which skews the mean cover-
age of these regions. Coverage differences between



































Figure 2 GC content distributions for capture subregions. (a) REC-set capture and (b) VCR-set capture.
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0.001) by the Mann-Whitney non-parametric test. Dif-
ferences in coverage seem to be driven almost entirely
by GC content. CCDS exons with very high GC con-
tent had coverage that was similar to regulatory
regions with high GC content, whereas CCDS exons
with very low GC content had depressed coverage
similar to conserved UTRs (Supplementary Figure 2 in
Additional file 1).
To determine whether the observed subregional differ-
ences in capture sequence data coverage resulted from
variability in the capture efficiencies, or alternatively, by
biases incurred during sequencing and alignment, we
compared the capture SOLiD sequencing data to their
equivalent regions in SOLiD WGS data [30]. First, we
determined that no particular subregion was especially
prone to mismapping by artificially generating reads
from these regions and mapping them back to the gen-
ome and by comparing the mapping scores (a measure of
the ratio of the best to the second best alignment score)
of real data aligned to each subregion (Supplementary
Tables 2 and 3 in Additional file 1) and found that
regions with very high variant densities (regulome, pre-
dicted exons) had mapping scores and mappabilities that
were very similar to regions with the lowest variant den-
sities (conserved UTRs); we conclude from this that the
high observed variant densities in the predicted exons
and regulome are likely not due to mismapping of reads.
In general, the relative coverage patterns observed in
WGS were similar to those from captured material (Fig-
ure 4a); however, two regions (miRNA and predicted
exons) performed better than expected when captured (a
positive value in Figure 4b), whereas both UTR regions
performed substantially worse than WGS. These data
show that some biases in recovery of sequence data from
some genomic regions were incurred during sequencing,
and not during the earlier capture phase.
Variant density in subregions
We examined the density of SNV sites in different cap-
ture subregions. All data were filtered to retain reads
with high mapping qualities and regions with 10× or
higher sequence read coverage (see Materials and meth-
ods; Supplementary Table 3 in Additional file 1). There
were differences in the discovery rate with different plat-
forms (Illumina approximately 1/1,500 bp in the CCDS
exome versus approximately 1/1,700 bp for SOLiD; Sup-
plementary Table 4a, b in Additional file 1). Both values
were similar to the variant densities observed in other
exon studies (for example, Thousand Genomes Pilot
Three [17]), but were considerably lower than those pre-
viously reported for the whole genome (approximately
1/1,000 bp) [31-33].
The evolutionarily conserved UTR portion of the
REC-set design harbored 10 to 25% fewer (Figure 5a)
variants (1/2,300 bp SOLiD, 1/1,625 bp Illumina) than
the CCDS exome, in stark contrast to the non-con-
served UTR portion of the VCR-set design (Figure 5b;
Supplementary Table 4b in Additional file 1), which
showed an 80 to 100% increase (1/925 bp SOLiD, 1/750
bp Illumina). Thus, there was an approximately 2.5-fold
differential in variant density between conserved and
non-conserved regions of the UTR.
Surprisingly, the predicted exons and regulatory
regions in the REC-set design exhibited more than two
times the variant density observed in the CCDS exome,
a value higher than the average rate of the whole gen-
ome (1/600 bp to 1/800 bp). This suggested that these
regions were either more tolerant to variation, or that
these regions have increased mutation rates compared
to the whole genome. Increasing or decreasing the strin-
gency of the variant calling parameters had little effect
on either the absolute variant density or the density
relative to the CCDS exome (data not shown).
To confirm that this observation was not an artifact of
allele-bias during the capture process, we compared
these results to those obtained from two WGS SOLiD
data sets [30,31] and filtered variants for predicted
exons and CCDS target regions. As expected, the Afri-
can genome that was previously sequenced showed a
higher variant density throughout the genome (1/900



























































Figure 3 Coverage distributions for capture subregions. (a)
Average coverage for subregions of REC-set design are shown as a
proportion of the average coverage of the CCDS subregion. (b)
Average coverage for subregions of VCR-set design are shown as a
proportion of the average coverage of the CCDS subregion. ‘R/V
specific’ refers to RefSeq/Vega exons not contained in the CCDS.
Bainbridge et al. Genome Biology 2011, 12:R68
http://genomebiology.com/2011/12/7/R68


































CCDS miRNA RefSeq Cons. UTRPred. Exons Regulome R/V SpecificWhole UTR VCR-set REC-set
Genomic Subregion
(b)
Figure 4 Normalized coverage distributions. (a) Coverage of genomic subregions, relative to the CCDS, after whole genome SOLiD
sequencing. Green, regions specific to REC-set; orange, regions specific to VCR-set; blue, shared regions. ‘R/V specific’ refers to RefSeq/Vega
exons not contained in the CCDS. (b) Proportional difference in relative coverage between capture-sequencing and WGS shows both
enrichment (values > 1) and depletion (values < 1) of certain genomic subregions after capture. Green, regions specific to REC-set; orange,
regions specific to VCR-set; blue shared regions.
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Figure 5 Single nucleotide variant densities. (a) Number of SNV substitutions per base pair, of REC-set subregions, as a proportion of the SNV
rate of the CCDS subregion. The absolute average value from SOLiD and Illumina sequencing is given above the data point. (b) Number of SNV
substitutions per base pair, of VCR-set subregions, as a proportion of the SNV rate of the CCDS subregion. The absolute average value from
SOLiD and Illumina sequencing is given above the data point. ‘R/V specific’ refers to RefSeq/Vega exons not contained in the CCDS.
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in each subregion examined here (Table 4c in Addi-
tional file 1). The relative variant densities, however,
when normalized to the CCDS exome, were approxi-
mately the same in both genomes. The observed high
density of variants in the predicted exons was even
more pronounced in these data, with predicted exon
regions (1/714 bp) having approximately 2.5× the muta-
tion rate of the CCDS (1/1,808 bp), and a 30 to 40%
increase over the genome as a whole. To ensure that
these results were not an artifact of high-throughput
sequencing, we examined the variant density of these
regions in HuRef [33]. The variant density in the CCDS
region of HuRef was slightly depressed compared to the
other two WGS datasets, but the relative variant density
for each region was similar or more pronounced (Sup-
plementary Table 4c in Additional file 1).
We examined the mutation spectrum of the observed
variants in different subregions (Additional file 2). Inter-
estingly, we found the transition:transversion ratio in
the CCDS region to be 3:1, in both capture and WGS
datasets, whereas across the whole genome the rate was
approximately 2:1 [34]. This value was also higher than
that seen in the regulome of 1.6:1. The mutation spec-
trum was significantly different for the regulome com-
pared to the CCDS exome; the number of C®T and
G®A mutations, as a proportion of the total number of
mutations, was significantly repressed in the regulome
compared to the CCDS, despite having a higher GC
content and a higher proportion of CpG dinucleotides,
which are known to be prone to mutation [35].
Interestingly, predicted exon subregions showed inter-
mediate levels of all mutation types when compared to
the CCDS and regulome regions. This implies that the
mutation spectrum alone cannot account for the
observed variant density.
Lastly, we hypothesized that predicted exons may have
variant density properties identical to that of introns.
Introns are thought to have a higher variant density
than the whole genome because they are frequently
transcribed [36]. Because no specifically intronic regions
were captured by our designs, we used the WGS data
and found that the intronic variant density (approxi-
mately 1/850) is slightly higher than that of the whole
genome (approximately 1/1,000), but still significantly
lower (P-value of approximately 0.0001) than that of
predicted exons (approximately 1/700) (Table 4c in
Additional file 1). It remains possible that the GC con-
tent of the predicted exons makes the variant density
higher than that seen in the remainder of the intron.
The high variant density we observed in the predicted
exons led us to examine the evolutionary conservation
of these regions relative to the introns and CCDS exons.
As expected, the CCDS exons were highly conserved
relative to the intronic regions. Although the predicted
exons mimicked the intronic regions by having a large
proportion of bases with neutral evolution scores, these
regions had more bases with both high and low conser-
vation when compared to the introns (Figure 6). We
next examined the minor allele frequency distribution,
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Figure 6 Distribution of phyloP scores across the CCDS (blue), intronic (red) and predicted exons (green).
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variants in the intronic, CCDS exome and predicted
exon regions for HuRef (Figure 7). Minor allele fre-
quency distributions for CCDS and predicted exons in
capture data were similar (data not shown). Although
12% of the intronic variants and only 9% of the CCDS
variants were private (unseen in public databases), fully
approximately 16% of the predicted exon variants were
not found in data from the Thousand Genomes Project.
This situation was reversed for fixed variants, with pre-
dicted exons having the smallest proportion (approxi-
mately 4%) compared to CCDS variants (approximately
6%).
Discussion
In this study we show the efficacy of DNA capture
sequencing and interrogation of variants in biologically
important loci outside of the CCDS exome. These
regions almost uniformly demonstrated decreased cap-
ture ability, as measured by average target coverage,
when compared to the CCDS regions. Overall, both Illu-
mina and SOLiD sequencing platforms showed similar
biases in coverage of genomic subregions when mea-
sured relative to the CCDS. Importantly, capture ability
appeared to be confounded by biases introduced by the
sequencing technology and correlated with GC content
of the target sequence, a known factor in short-read
sequencing [37,38]. Particularly, conserved UTR regions,
which are approximately 30% GC, and regulatory
regions, which are approximately 70% GC, had approxi-
mately half of the sequence depth of coverage as the
CCDS regions, approximately 50% GC. When compared
to WGS (non-capture) data the same general biases
were evident. However, the act of capturing the targeted
regions seems to exacerbate the coverage bias by an
additional 5 to 10%. The exceptions to this are the pre-
dicted exons and microRNA, where the coverage was
higher than expected and the UTR regions where the
coverage was as much as 25% lower than expected from
the WGS data. This effect may be due to steric hin-
drance of probe-target binding introduced by secondary
structure present in the UTR regions. These results
imply that naively capturing biologically relevant loci
other than the CCDS will require 20 to 40% more
sequencing data to be generated than expected from the
CCDS. It may be possible, however, to alter the capture
reagent, perhaps by increasing the representation of
some probes, in order to compensate for the empirically
measured coverage biases and thus help normalize the
coverage when capturing CCDS and other elements.
To our knowledge, this is the first targeted-sequence
capture study of a genome-wide, diverse set of biologi-
cally important elements, allowing the investigation of
variant densities in functionally relevant loci that have
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Figure 7 Minor allele frequency distributions for variants in HuRef subregions: predicted exons (green), CCDS exons (blue) and introns
(red). ‘Private’ indicates the variant was not found in the Thousand Genomes Project.
Bainbridge et al. Genome Biology 2011, 12:R68
http://genomebiology.com/2011/12/7/R68
Page 8 of 12
whole genome sequencing. Using both Illumina and
SOLiD sequencing, we demonstrate the ability to find
variants across a significantly larger target region than
the CCDS. As capture sequencing enables high levels of
sequence coverage, we were able to discover rare (pri-
vate) variants in each sample, using similar amounts of
data to that used by low-coverage, whole-genome tech-
niques that are better suited for common variant
discovery.
Illumina sequencing consistently showed higher var-
iant densities than SOLiD sequencing. This discrepancy
is likely due to differences in variant filtering parameters
used for the two different sequencing types. However, it
may also reflect the inherently higher accuracy of
SOLiD sequencing [37]. Importantly, when measured
relative to the CCDS variant density, different subre-
gions showed remarkably similar variant densities for
both sequencing platforms. Variant densities, however,
were found to vary in different subregions of the gen-
ome, likely due to evolutionary conservation and base
composition of these regions. The evolutionarily con-
served CCDS exome and UTR regions showed variant
densities of 1/1,600 to 1/1,850 bp, considerably less than
the whole genome rate of 1/1,000 bp, which presumably
reflects the result of purifying selection acting to remove
deleterious variants. Exons specific to RefSeq, which are
not in the CCDS, showed intermediate levels of variant
density, 1/1,200 bp. This is likely because these loci are
less essential to the organism, and mutations in these
regions are less likely to be deleterious. Unlike the cod-
ing regions, the regulome showed a variant density
higher than the whole genome. While this is likely due
to the GC content of the regulome, we found that C®T
and G®A mutations were underrepresented as a por-
tion of all variants when compared to the CCDS. This is
significant because 5-methyl-cytosine bases in CpG
dinucleotides, which are over-represented in regulatory
regions, are prone to spontaneous deamination to uracil
and subsequent repair to thymine [39]. This would indi-
cate there is strong selective pressure to maintain cyto-
sine and guanine representation in the regulome
compared to the CCDS exome.
Of all the regions interrogated, the predicted exons
showed the highest variant density, 1/660 bp. Although
these exons have a higher GC content than the CCDS,
it is considerably lower than the regulome, indicating
that the increased mutability of GC-rich sequence con-
tent cannot fully account for the variant density. How-
ever, we observed that the intronic variant density in
WGS studies was also considerably higher than that of
the whole genome. It has been reported that transcribed
regions have higher variant densities than non-tran-
scribed regions [40,41] and we surmise, therefore, that
the observed variant density is a combination of these
regions being actively transcribed and their high GC
content. As expected from the high variant density, pre-
dicted exon regions showed a slightly higher proportion
of bases with faster than neutral evolution rates than
when compared to intronic regions. Unexpectedly, pre-
dicted exons also showed a slightly higher proportion of
conserved bases when compared to intronic regions.
The ‘exonization’ of intronic elements is well documen-
ted [42-45] and computationally predicted exons have
been detected in mature mRNA from RNA-seq experi-
ments [46]. In this work we interrogated predicted exons
that are flanked by canonical splice-sites and exist within
known CCDS genes and thus are good candidates for
inclusion in mature RNA and subsequent translation.
Exons are thought to be protected from mutation [47]
and the higher mutation rates in predicted-exons may
then be a source of evolutionary diversity.
Conclusions
This work has important implications for the large
number of CCDS-based exome-capture experiments
currently being reported. Specifically, caution should be
used when extrapolating CCDS results to the entire
human exome. Regions outside of the CCDS are more
difficult to sequence, map and capture and require more
raw sequence data than otherwise expected. Further,
studies that seek to characterize human coding variation
across a large number of individuals should use a
diverse set of gene models to better measure and under-
stand variation in less conserved coding elements. Con-
sideration of non-CCDS regions in general will
complicate sequence-based genome-wide disease studies
due to the wider range of variant densities they exhibit,




DNA was obtained from the Corriel biorepository
(catalog id GM12812). DNA was obtained from indivi-
duals under written informed consent for participation
in the study. The study was approved by the institu-
tional review board at Baylor College of Medicine and
was conducted in accordance with the Helsinki
declaration.
Target regions and probe design
All annotations, except for miRNA, were downloaded
from UCSC Genome Browser [48] (hg18) on 1 Octo-
ber 2009. Coding regions: exons for the CCDS, RefSeq
and Vega gene sets were all obtained in their entirety
and non-coding regions were removed internally. Con-
served UTRs: UTR regions were selected from the
RefSeq and Vega gene sets. A region was considered
Bainbridge et al. Genome Biology 2011, 12:R68
http://genomebiology.com/2011/12/7/R68
Page 9 of 12
conserved if it had an LOD score ≥100 as determined
by the phastCons [24] package using 17 vertebrate
genomes (17-way most conserved track). miRNA: these
annotations were obtained from miRNA base v13. Pre-
dicted exons: these annotations were obtained from
Contrast and GenScan. Only predicted exons that
occurred within the introns of known genes were used.
Regulatory regions: these regions were obtained from
the ORegAnno track and the Hudson Alpha transcrip-
tion factor binding site (CHiP-seq) tracks. Only ORe-
gAnno annotations that were < 50 bp were considered
so as to remove non-transcription factor binding site
regulatory regions and limit the total target size.
CHiP-seq sites were only considered if they had an
enrichment score of 300 or greater. Solution capture
probes were designed and produced by Roche Nimble-
Gen (Madison WI, USA) as previously described [6].
Nonconserved UTR: approximately 1,500 exons were
randomly selected from 5’ and 3’ UTRs of Vega genes
without any consideration for their conservation; how-
ever, they were always either the first or last exon in
the annotated gene. RefSeq/Vega-specific regions: these
regions are derived by algorithmically subtracting the
CCDS regions from the combined Vega/RefSeq
regions. For the purposes of this paper, derived regions
< 50 bp were not considered as small regions, and
regions at the edges of targets show lower coverage,
generally.
Target regions are available as BED files in Additional
files 3 and 4.
Library preparation
Precapture libraries for SOLiD (2 μg) were hybridized
in solution according to the manufacturer’s protocol
with minor revisions. Specifically, hybridization enhan-
cing oligos TrTA-A and SOLiD-B replaced oligos PE-
HE1 and PE-HE2 and post-capture ligation-mediated
PCR was performed using 12 cycles. Capture libraries
were quantified using PicoGreen (catalog number
P7589) and their size distribution analyzed using the
Agilent Bioanalyzer 2100 DNA Chip 7500 (catalog
number 5067-1506). Capture efficiency was evaluated
by performing a quantitative PCR-based SYBR Green
assay (Applied Biosystems, Foster City CA, USA Inc.;
catalog number 4368708) with built-in controls
(RUNX2, PRKG1, SMG1, and NLK). Capture library
enrichment was estimated at seven to nine cycles over
background by quantitative PCR. Captured libraries
were further processed for sequencing, with approxi-
mately 6 to 12 Gbs of sequence generated per capture
library on either SOLiD V3 or V4 instruments
(Applied Biosystems, Inc.). A complete capture proto-
col can be found on the Baylor Human Genome
Website [49]. Illumina library preparation was con-
ducted as previously described [6].
Sequence data generation, alignment and variant calling
SOLiD data were aligned to the human genome
(hg18) with BFast [50] and Illumina data with BWA
[51]. Variants were filtered for quality as previously
described [6]. Briefly, read qualities were recalibrated
with GATK and a minimum quality score of 30 was
required; also, the variant must have been present in
at least 15% of the reads that cover the position. In
addition, prior to variant calling reads with low (< 11)
mapping qualities (a value based on the ratio of the
best alignment score to the second best alignment
score) were removed. This typically eliminates
approximately 5 to 10% of the aligned reads.
Sequence data were produced from either SOLiDv3
or Illumina GAII sequencing machines and are avail-
able from the Sequence Read Archive [52] with acces-
sion [SRP004501.1].
Additional material
Additional file 1: Supplementary data and statistics. Experimental
design, capture statistics, regional description statistics, as well as whole
genome statistics.
Additional file 2: Mutation spectrum. The mutation spectrum,
transition:transversion ratio of discovered variants ordered by subregion.
Additional file 3: REC-set targets. Targeted regions in the REC-set.
Additional file 4: VCR-set targets. Targeted regions in the VCR-set.
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